Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Profit After Tax (2021 - 2025)

Coeptis Therapeutics Holdings has reported Profit After Tax over the past 5 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$1.9 million for Q4 2025, up 33.56% from a year ago — trailing twelve months through Dec 2025 was -$12.6 million (down 17.84% YoY), and the annual figure for FY2025 was -$12.3 million, down 14.95%.
  • Profit After Tax for Q4 2025 was -$1.9 million at Coeptis Therapeutics Holdings, up from -$2.9 million in the prior quarter.
  • Over the last five years, Profit After Tax for COEPW hit a ceiling of $17.5 million in Q4 2023 and a floor of -$29.9 million in Q4 2021.
  • Median Profit After Tax over the past 5 years was -$3.0 million (2024), compared with a mean of -$3.7 million.
  • Biggest five-year swings in Profit After Tax: tumbled 443.47% in 2022 and later surged 695.01% in 2023.
  • Coeptis Therapeutics Holdings' Profit After Tax stood at -$29.9 million in 2021, then skyrocketed by 90.16% to -$2.9 million in 2022, then surged by 695.01% to $17.5 million in 2023, then tumbled by 116.66% to -$2.9 million in 2024, then soared by 33.56% to -$1.9 million in 2025.
  • The last three reported values for Profit After Tax were -$1.9 million (Q4 2025), -$2.9 million (Q3 2025), and -$4.3 million (Q2 2025) per Business Quant data.